Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvex (MOVE) Cash & Equivalents (2020 - 2025)

Corvex filings provide 3 years of Cash & Equivalents readings, the most recent being $2.8 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 64.22% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 64.22% decrease, with the full-year FY2025 number at $2.8 million, down 64.22% from a year prior.
  • Cash & Equivalents hit $2.8 million in Q4 2025 for Corvex, up from $293000.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $16.9 million in Q2 2024 to a low of $293000.0 in Q3 2025.
  • Median Cash & Equivalents over the past 3 years was $2.1 million (2024), compared with a mean of $4.9 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 358.09% in 2024 and later crashed 98.09% in 2025.
  • Corvex's Cash & Equivalents stood at $1.7 million in 2023, then skyrocketed by 358.09% to $7.9 million in 2024, then plummeted by 64.22% to $2.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $2.8 million (Q4 2025), $293000.0 (Q3 2025), and $322000.0 (Q2 2025) per Business Quant data.